Publication:
Myelin oligodendrocyte glycoprotein antibodies in genetic leukodystrophies

dc.contributor.coauthorEroğlu Ertuğrul, Nesibe Gevher
dc.contributor.coauthorPekgüzel, Faruk
dc.contributor.coauthorGuenbey, Ceren
dc.contributor.coauthorTopçu, Meral
dc.contributor.coauthorOğuz, Kader K.
dc.contributor.coauthorÖzkara, Hatice Asuman
dc.contributor.coauthorAnlar, Banu
dc.contributor.departmentKUTTAM (Koç University Research Center for Translational Medicine)
dc.contributor.departmentSchool of Medicine
dc.contributor.facultymemberYes
dc.contributor.kuauthorDoran, Tansu
dc.contributor.kuauthorVural, Atay
dc.contributor.kuauthorYousefi, Mohammadreza
dc.contributor.schoolcollegeinstituteResearch Center
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:18:37Z
dc.date.issued2022
dc.description.abstractAccumulation of intermediate metabolites due to enzyme deficiencies and demyelination can provoke inflammation in genetic leukodystrophies. Thirty patients with genetic leukodystrophy and 48 healthy control sera were tested for anti-myelin oligodendrocyte glycoprotein (MOG) antibodies by fixed and/or live cell-based assays. MOG-IgG was detected in two late infantile metachromatic leukodystrophy (MLD) cases, both of which were also weakly positive for IgG1, and one with IgG3 as the dominant anti-MOG IgG subclass. MOG-IgG was borderline positive in a vanishing white matter (VWM) disease patient. These results suggest that inherited metabolic or degenerative processes can have an autoimmune component, possibly as an epiphenomenon.
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccessNO
dc.description.peerreviewstatusN/A
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuTÜBİTAK
dc.description.sponsorshipThis study was supported by the Hacettepe University Scientific Research Coordination Unit, TSA-2017-12891. The live cell-based assay used in this study was performed with a TUBITAK 3501 grant from The Scientific and Technological Research Council of Turkey, grant number 118S397. The authors acknowledge the use of the services and facilities of the Koc University Research Center for Translational Medicine (KUTTAM) , funded by the Department of Strategy and Budget, Presidency of Turkey. We thank our patients and their families for their participation in the study.
dc.description.studentonlypublicationNo
dc.description.studentpublicationYes
dc.description.versionN/A
dc.identifier.WoSQuartileQ3
dc.identifier.doi10.1016/j.jneuroim.2022.577916
dc.identifier.eissn1872-8421
dc.identifier.embargoN/A
dc.identifier.grantno118S397
dc.identifier.issn0165-5728
dc.identifier.pubmed35752102
dc.identifier.scopus2-s2.0-85132503287
dc.identifier.urihttps://doi.org/10.1016/j.jneuroim.2022.577916
dc.identifier.urihttps://hdl.handle.net/20.500.14288/10411
dc.identifier.volume369
dc.identifier.wos000819442600003
dc.keywordsLeukodystrophy
dc.keywordsMyelin oligodendrocyte glycoprotein
dc.keywordsFixed cell-based assay
dc.keywordsLive cell-based assay
dc.keywordsMOG antibody disease (MOGAD)
dc.keywordsDemyelination
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofJournal of Neuroimmunology
dc.relation.openaccessN/A
dc.relation.projectOtoimmün Nörolojik Hastalıklarda İmmünopatogenezin ve Klinik Özelliklerle İlişkili Immünolojik Parametrelerin Araştırılması
dc.rightsN/A
dc.subjectImmunology
dc.subjectNeurosciences
dc.titleMyelin oligodendrocyte glycoprotein antibodies in genetic leukodystrophies
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorYousefi, Mohammadreza
local.contributor.kuauthorDoran, Tansu
local.contributor.kuauthorVural, Atay
relation.isGoalOfPublicationa9786601-9431-4553-9a46-013bb366fb87
relation.isGoalOfPublication.latestForDiscoverya9786601-9431-4553-9a46-013bb366fb87
relation.isOrgUnitOfPublication91bbe15d-017f-446b-b102-ce755523d939
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscovery91bbe15d-017f-446b-b102-ce755523d939
relation.isParentOrgUnitOfPublicationd437580f-9309-4ecb-864a-4af58309d287
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscoveryd437580f-9309-4ecb-864a-4af58309d287
relation.isProjectOfPublicationacec34a8-1af9-438c-b703-e0b47154551a
relation.isProjectOfPublication.latestForDiscoveryacec34a8-1af9-438c-b703-e0b47154551a

Files